Exciting Developments in the Pipeline in HER2+ MBC
A multidisciplinary panel of health care professionals and a patient advocate comment on their excitement about novel therapies in the pipeline for HER2-positive metastatic breast cancer.
Novel Therapies for HER2+ Breast Cancer and Brain Metastases
Sara A. Hurvitz, MD, and Julia A. LaBarbera, NP, of UCLA, highlight the safety and efficacy profiles of newer novel treatment options available for HER2-positive breast cancer and brain metastases.
Treatment Strategies for HER2+ Breast Cancer and Brain Metastases
Treatment recommendations for patients with HER2-positive metastatic breast cancer, like Erika Rich, upon identification of lesions in the brain.
HER2+ MBC: Preparing Patients for Chemotherapy
Adverse events commonly associated with chemotherapies used to treat HER2-positive metastatic breast cancer, and recommendations to help equip patients with knowledge about what to expect during their treatment journey.
Subcutaneous Therapies for HER2+ MBC
Julia A. LaBarbera, NP, reacts to the treatment approach used for a patient with HER2-positive metastatic breast cancer, and highlights the benefits of new subcutaneous injections of trastuzumab and pertuzumab that are available.
Common Symptoms Associated With HER2+ Metastatic Breast Cancer
Patient advocate Erika Rich compares initial symptoms that prompted her to seek a medical evaluation with symptoms commonly associated with HER2-positive metastatic breast cancer.
HER2+ Metastatic Breast Cancer Treatment Advances
A discussion regarding treatment advances in HER2-positive metastatic breast cancer, a heterogeneous disease.